Detalles de la búsqueda
1.
Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer.
Future Oncol;
19(34): 2277-2289, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37746835
2.
The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.
Int J Clin Oncol;
25(2): 396-402, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31776732
3.
A Difference in the Incidences of Hypersensitivity Reactions to Original and Generic Taxanes.
Chemotherapy;
62(2): 134-139, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-27997900
4.
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study.
Lancet Gastroenterol Hepatol;
2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38823398
5.
Safety Following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac.
Vaccines (Basel);
11(2)2023 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36851234
6.
Modified albumin-bilirubin predicted survival of unresectable hepatocellular carcinoma patients treated with immunotherapy.
World J Gastrointest Oncol;
15(10): 1771-1783, 2023 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37969413
7.
Effect of Primary Tumor Location on Second- or Later-Line Treatment With Anti-Epidermal Growth Factor Receptor Antibodies in Patients With Metastatic Colorectal Cancer: A Retrospective Multi-Center Study.
Front Oncol;
12: 813009, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35242708
8.
Vaccine-Related adverse events following AZD1222 (ChAdOx1-nCoV-19) Covid-19 vaccine in solid malignancy patients receiving cancer treatment, as compared to age-matched healthy controls.
Hum Vaccin Immunother;
18(6): 2094149, 2022 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35776836
9.
Efficacy, Safety, and Patient-Reported Outcomes of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Thailand: A Multicenter Prospective Study.
JCO Glob Oncol;
8: e2200205, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36455172
10.
Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine.
Vaccines (Basel);
10(10)2022 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36298478
11.
Durability of Immune Response to ChAdOx1-nCoV-19 Vaccine in Solid Cancer Patients Undergoing Anticancer Treatment.
Vaccines (Basel);
10(10)2022 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36298528
12.
Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study.
EClinicalMedicine;
52: 101608, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35971500
13.
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer.
NEJM Evid;
1(8): EVIDoa2200015, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-38319896
14.
Protein kinase D1 promotes anchorage-independent growth, invasion, and angiogenesis by human pancreatic cancer cells.
J Cell Physiol;
226(4): 1074-81, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20857418
15.
Effects of Complementary and Alternative Medicine on Chemotherapy Delivery in Thai Patients.
Asian Pac J Cancer Prev;
22(12): 3977-3983, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34967579
16.
Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial.
Lancet Gastroenterol Hepatol;
6(12): 1015-1024, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34626550
17.
Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001.
Clin Cancer Res;
27(13): 3649-3660, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33879458
18.
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer.
Clin Cancer Res;
27(23): 6413-6423, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34433653
19.
Association between Vitamin D Receptor Single-Nucleotide Polymorphisms and Colorectal Cancer in the Thai Population: A Case-Control Study.
Biomed Res Int;
2020: 7562958, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32626760
20.
Effects of ABCC2 and SLCO1B1 Polymorphisms on Treatment Responses in Thai Metastatic Colorectal Cancer Patients Treated with Irinotecan-Based Chemotherapy
Asian Pac J Cancer Prev;
19(10): 2757-2764, 2018 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-30360603